查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1729624

日本手术缝线市场规模、份额、趋势及预测（按类型、线材、应用、最终用途和地区），2025 年至 2033 年

Japan Surgical Sutures Market Size, Share, Trends and Forecasts by Type, Filament, Application, End Use, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 120 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2024 年，日本手术缝线市场规模价值 3.19 亿美元。展望未来， IMARC Group估计到 2033 年市场规模将达到 5.53 亿美元，2025 年至 2033 年的复合年增长率为 6.30%。人口老化、外科手术增加以及慢性病病例增加推动了市场的发展。此外，人们对可吸收缝线和精密手术技术的日益青睐也促进了市场的成长。政府支持、医疗基础设施扩张以及医疗支出的增加进一步促进了日本手术缝合线市场份额的成长。

日本手术缝合线市场的主要驱动力是人口老化和慢性病发病率上升导致手术普及率上升。日本老年人口已达到前所未有的3,625万人，占总人口的29.3%，这一比例为全球最高。其中，女性2053万人，男性1572万人。此外，去年有 914 万名老年人就业。日本人口连续13年呈现下降趋势，预测2040年，老龄人口将占日本总人口的34.8%。日本是世界上预期寿命最高的国家之一，导致老龄人口不断增长，需要透过手术干预治疗心血管疾病、骨科疾病和癌症等疾病。根据日本手术缝合线市场研究报告，微创手术技术的进步正在推动对高品质缝合线的需求，以增强伤口癒合并缩短恢復时间。此外，政府支持医疗基础设施发展和技术创新的措施确保了人们能够获得先进的医疗产品，进一步促进了市场扩张。

此外，人们越来越倾向于采用可吸收缝线来改善患者的治疗效果并减少术后併发症。人们对精准手术和机器人辅助手术的日益关注，也增加了对具有优异抗拉强度和生物相容性的缝合线的需求。根据日本手术缝线市场分析，不断上涨的医疗支出和支持先进外科手术的报销政策鼓励医院和诊所投资高性能缝线。日本的医疗福利产业目前是第三大产业，预计到 2035 年至 2040 年将成为第一大产业。预测显示，到 2040 年，医疗保健支出将增至 89 兆日圆（约 6,000 亿美元），比 2023 年的水准增加 1.6 倍。如果税率保持稳定，这种情况可能会导致 27 兆日圆（约 1,800 亿美元）的资金缺口。此外，主要市场参与者的存在以及旨在增强缝合材料和涂层的持续研发努力进一步促进了日本手术缝合线市场的成长。

日本手术缝合线市场趋势：

越来越多地采用可生物降解和抗菌缝合线

日本手术缝合线市场的一个重要趋势是人们对可生物降解和抗菌缝合线的偏好日益增长。可生物降解缝合线，特别是由聚乙醇酸和聚乳酸製成的缝合线，因其能够自然溶解、无需拆线并降低感染风险而受到关注。此外，由于人们对手术部位感染（SSI）的担忧日益增加，用于防止伤口部位细菌定植的抗菌涂层缝线的需求也增加。日本手术后手术部位感染（SSI）的总发生率为 4.2%。相较之下，涉及肠道（以共生菌浓度高而闻名）的胃肠手术的发生率仅为 7.2%。随着医疗保健提供者强调患者安全和术后结果，製造商正专注于开发具有增强抗菌性能和生物相容性的缝线。这一趋势推动了缝合材料和涂层的创新，进一步加强了日本手术缝合线的市场份额。

智慧缝合线和奈米技术整合的进展

智慧缝合线和奈米技术与手术缝合线的结合正在彻底改变日本市场。嵌入感测器的智慧缝合线可透过检测感染、pH 值变化和组织压力来即时监测伤口癒合。这些缝合线提供了重要的见解，有助于早期诊断和及时医疗干预，提高患者的康復率。此外，具有药物洗脱特性的奈米技术增强缝合线因其能够进行局部治疗、减少发炎和增强组织再生的能力而越来越受欢迎。随着日本在医疗技术进步方面继续保持领先地位，对下一代缝线研发的投资正在增加，从而促进了创新并改善了各个医学专业的手术效果。 2024 年 8 月 6 日，Shinobi Therapeutics 从日本医疗研究发展机构 (AMED) 获得 5,900 万美元的资助，用于进一步开发针对 GPC3+ 实体瘤的 iPS-T 细胞疗法。此次融资使该公司的总融资额增加至 1.19 亿美元，并增加了新投资者 Yosemite 和三菱 UFJ Capital。

机器人辅助和微创手术的需求不断增长

机器人辅助和微创手术技术的日益普及是日本手术缝线市场的重要趋势之一。 2024年5月9日，索尼打造了一款具有自动器械交换和精确控制功能的微手术辅助机器人，计划于横滨举行的ICRA2024上亮相。这项创新旨在透过模仿涉及静脉和神经的复杂手术的手部动作来解决日本外科医生短缺的问题。在 2024 年 2 月于爱知医科大学进行的一项试验中，该机器人成功实施了世界上第一例利用自动器械交换的微血管吻合术，取得了重要的里程碑。外科医生越来越多地利用机器人系统进行精密手术，这需要使用具有优异抗拉强度和灵活性的专用缝线。微创手术需要较小的切口，这增加了对微型和倒钩缝合线的需求，因为这些缝合线能够以最小的组织创伤实现安全的伤口闭合。此外，由于医院和外科中心优先考虑效率和缩短恢復时间，製造商正在开发适合腹腔镜和机器人手术的缝线。随着日本医疗保健产业采用先进的外科手术技术，预计这一趋势将持续下去，从而为日本外科缝线市场带来积极的前景。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：日本外科缝合线市场-简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争情报

第五章：日本手术缝合线市场概况

  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）

第六章：日本外科缝合线市场-分类：依类型

  • 可吸收
    • 概述
  • 不可吸收
    • 概述

第七章：日本外科缝合线市场-细分：按长丝

  • 单价
    • 概述
  • 多价
    • 概述

第 8 章：日本外科缝线市场 - 细分：按应用

  • 眼科手术
    • 概述
  • 心血管外科
    • 概述
  • 骨科手术
    • 概述
  • 神经外科
    • 概述
  • 其他的

第 9 章：日本手术缝线市场 - 分裂：最终用途别

  • 医院
    • 概述
  • 门诊手术中心及诊所
    • 概述

第十章：日本手术缝线市场-竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳获胜策略
  • 竞争仪錶板
  • 公司评估象限

第 11 章：关键参与者简介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company F
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company G
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company H
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company I
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company J
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 12 章：日本手术缝线市场-产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 驱动程式
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 13 章：附录

简介目录
Product Code: SR112025A18003

The Japan surgical sutures market size was valued at USD 319 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 553 Million by 2033, exhibiting a CAGR of 6.30% from 2025-2033. The market is driven by an aging population, increasing surgical procedures, and rising cases of chronic diseases. Additionally, the growing preference for absorbable sutures and precision surgical techniques is enhancing market growth. Government support, healthcare infrastructure expansion, and rising healthcare expenditures further contribute to the Japan surgical sutures market share.

The Japan surgical sutures market is primarily driven by the rising prevalence of surgical procedures due to an aging population and increasing incidences of chronic diseases. Japan's senior demographic has attained an unprecedented figure of 36.25 Million, constituting 29.3% of the overall population, which is the highest percentage in the world. Of this group, 20.53 Million are women and 15.72 Million are men. Additionally, last year saw 9.14 Million seniors engaged in the workforce. Following a trend of population decline for 13 consecutive years, forecasts suggest that by 2040, the elderly will represent 34.8% of Japan's total population. Japan has one of the world's highest life expectancies, leading to a growing elderly demographic that requires surgical interventions for conditions such as cardiovascular diseases, orthopedic disorders, and cancer. According to the Japan surgical sutures market research report, advancements in minimally invasive surgical techniques are fueling demand for high-quality sutures that enhance wound healing and reduce recovery time. Moreover, government initiatives supporting healthcare infrastructure development and technological innovation further contribute to the market's expansion by ensuring access to advanced medical products.

In addition, the growing adoption of absorbable sutures is driven by the preference for improved patient outcomes and reduced post-operative complications. The increasing focus on precision surgery and robotic-assisted procedures is increasing the need for sutures with superior tensile strength and biocompatibility. According to the Japan surgical sutures market analysis, rising healthcare expenditures and reimbursement policies that support advanced surgical procedures encourage hospitals and clinics to invest in high-performance sutures. Japan's medical and welfare sector, currently the third largest industry, is anticipated to become the largest by the years 2035 to 2040. Projections indicate that healthcare expenditures will increase to ¥89 Trillion (approximately USD 600 Billion) by 2040, representing a 1.6-fold increase from the levels observed in 2023. Should tax rates remain stable, this situation may result in a funding deficit of ¥27 Trillion (around USD 180 Billion). Furthermore, the presence of key market players and continuous research and development efforts aimed at enhancing suture materials and coating further bolster Japan surgical sutures market growth.

Japan Surgical Sutures Market Trends:

Increasing Adoption of Biodegradable and Antimicrobial Sutures

A significant trend in the Japan surgical sutures market is the growing preference for biodegradable and antimicrobial sutures. Biodegradable sutures, particularly those made from polyglycolic acid and polylactic acid, are gaining attention due to their ability to dissolve naturally, avoiding the need for suture removal, and decreasing the risk of infection. Additionally, antimicrobial-coated sutures, designed to prevent bacterial colonization at the wound site, are witnessing increased demand in response to rising concerns about surgical site infections (SSIs). The general occurrence of surgical site infections (SSI) following operations in Japan stands at 4.2%. In contrast, the incidence rate for gastrointestinal surgeries that involve the intestinal tract, known for its high concentration of commensal bacteria, is recorded at 7.2%. With healthcare providers emphasizing patient safety and postoperative outcomes, manufacturers are focusing on developing sutures with enhanced antimicrobial properties and biocompatibility. This trend is driving innovation in suture materials and coatings, further strengthening the Japan surgical sutures market share.

Advancements in Smart Sutures and Nanotechnology Integration

The integration of smart sutures and nanotechnology into surgical sutures is revolutionizing the market in Japan. Smart sutures, embedded with sensors, offer real-time monitoring of wound healing by detecting infection, pH changes, and tissue stress. These sutures provide critical insights that help in early diagnosis and timely medical intervention, improving patient recovery rates. Additionally, nanotechnology-enhanced sutures with drug-eluting properties are gaining popularity for their ability to deliver localized treatment, reduce inflammation, and enhance tissue regeneration. As Japan continues to lead in medical technology advancements, investments in research and development for next-generation sutures are rising, fostering innovation and improving surgical outcomes across various medical specialties. On 6th August 2024, Shinobi Therapeutics obtained a grant of USD 59 million from Japan's Agency for Medical Research and Development (AMED) to further develop its iPS-T cell therapy targeting GPC3+ solid tumors. This funding increases the company's total financial backing to USD119 million, with the addition of new investors Yosemite and Mitsubishi UFJ Capital.

Growing Demand for Robotic-Assisted and Minimally Invasive Surgeries

The increasing adoption of robotic-assisted and minimally invasive surgical techniques is one of the significant Japan surgical sutures market trends. On 9th May 2024, Sony created a microsurgery assistance robot featuring automatic instrument exchange and precise control, scheduled to be unveiled at ICRA2024 in Yokohama. This innovation aims to tackle the shortage of surgeons in Japan by mimicking hand movements for intricate procedures involving veins and nerves. In a trial conducted in February 2024 at Aichi Medical University, the robot achieved a significant milestone by successfully executing the world's first microvascular anastomosis utilizing automated instrument exchange. Surgeons are increasingly utilizing robotic systems for precision-driven procedures, necessitating the use of specialized sutures with superior tensile strength and flexibility. Minimally invasive surgeries, which require smaller incisions, have heightened the demand for micro and barbed sutures that enable secure wound closure with minimal tissue trauma. Furthermore, as hospitals and surgical centers prioritize efficiency and reduced recovery times, manufacturers are developing sutures tailored for laparoscopic and robotic surgeries. This trend is expected to continue as Japan's healthcare sector embraces advanced surgical techniques, creating a positive Japan surgical sutures market outlook.

Japan Surgical Sutures Industry Segmentation:

Analysis by Type:

  • Absorbable
  • Nonabsorbable

Absorbable sutures are essential in the Japanese surgical sutures market, especially since they ensure fast healing of wounds and a reduced number of suture removals. They are made from synthetic polymers or natural materials such as catgut and dissolve inside the body after some time. Increasing usage in internal tissue repair, particularly in surgeries including gastrointestinal, gynecological, and orthopedic surgeries, has enhanced the demand in the market. Additionally, developments in suture coatings as well as antimicrobial properties make them a more effective option for the surgeons who focus on the reduction of infection risks and better recovery of patients.

Nonabsorbable sutures provide long-lasting tissue support. Therefore, the sutures come in handy with procedures that have a need to close wounds over a long duration, such as cardiovascular and orthopedic surgery. Unlike their absorbable varieties, they consist of materials that include nylon, polypropylene, and silk, which will not degrade once placed inside the body. Chronic disease-related surgeries have risen in Japan. Cardiovascular and neurosurgical applications are major growth areas. More importantly, novel technologies developed within the suture material enhance the performance, safety of wound closure, and patient outcomes from surgical procedures by decreasing complications, such as dehiscence in patients whose wound healing takes an extended time to occur.

Analysis by Filament:

  • Monovalent
  • Multivalent

Monofilament sutures consist of a single, smooth strand. Therefore, there is minimal bacterial contamination risk, and tissue trauma is minimized. The structure provides easy passage through tissues; they are especially handy for delicate procedures such as cardiovascular and plastic surgeries. The demand for monofilament sutures has increased as the demand for minimally invasive surgery has increased in Japan. Advance developments in suture materials, such as developments in absorbable and nonabsorbable substances with increased tensile strengths, add to this increase in popularity among surgeons looking for reliable, friction-reducing sutures that enhance wound healing with minimal tissue irritation.

Multifilament sutures comprise twisted or braided numerous strands put together, thereby yielding excellent flexibility, secure knots, and tensile strength. Such multifilament sutures are essential in relatively complex surgical procedures that require solid support to wounds, such as orthopedic and gastrointestinal surgeries. In Japan, the continually increasing rates of surgical procedures have led to an increased demand for multifilament sutures, especially in high-tension areas. However, since their braided structure can harbor bacteria, antimicrobial-coated variants are increasingly developed to minimize infection risks, ensuring their continued use in critical surgical applications requiring enhanced durability and stability.

Analysis by Application:

  • Ophthalmic Surgery
  • Cardiovascular Surgery
  • Orthopedic Surgery
  • Neurological Surgery
  • Others

Fine-gauge sutures in ophthalmic surgeries are used to minimize tissue damage and ensure speedy and effective healing. Improvement in the prevalence of cataracts, glaucoma, and retinal disorders in Japan will require more fine-gauge sutures particularly for delicate procedures in the eye. Monofilament and absorbable sutures are widely used to minimize scarring and promote recovery. The advancement in suture materials, including ultra-thin and biodegradable ones, improves surgical outcomes by reducing inflammation and promoting smooth tissue integration.

Cardiovascular surgeries require sutures that are very strong, biocompatible, and resistant to constant blood flow and tissue movement. In Japan, the incidence of heart diseases has risen, which has subsequently raised the use of durable and nonabsorbable sutures in valve replacement surgeries, and bypass surgeries. Monofilament sutures are preferred for reducing infection risks, while synthetic absorbable options provide temporary support. Innovations in coated sutures with enhanced tensile strength contribute to improved patient outcomes and long-term surgical success.

Orthopedic procedures require the use of sutures with good tensile strength to support the healing of the musculoskeletal system. Due to an aged population and sporting injuries, demands for strong sutures used to repair ligaments, reconstruct the joint, or fix bones, have increased over the years. Both absorbable and non-absorbable sutures are used based on the procedure. Advances in suture coatings and braided designs allow for increased security of knots for stable wound closure with minimal complications during healing.

Neurosurgical sutures must be highly precise and stable while minimizing tissue reaction. Brain and spinal surgery have been significantly on the rise in Japan, thus increasing the demand for ultra-fine biocompatible sutures. Monofilament sutures are commonly used for dural closure. These sutures maintain tissue integrity for a longer period of time as they are nonabsorbable. Microsurgical sutures with advancements such as antimicrobial coatings and improved elasticity are making it possible to be more precise during surgery and leading to better patient recovery, which makes them inevitable for delicate neurological procedures requiring cautious wound closure.

Analysis by End Use:

  • Hospitals
  • Ambulatory Surgical Centers and Clinics

Japan has a large network of hospitals managing a wide variety of complicated and critical cases, which form the main demand source for surgical sutures. Given the population is aging, along with increasing incidence of chronic diseases, advanced sutures for cardiovascular, orthopedic, and neurological surgery procedures are witnessing growth in demand. Hospitals also have a range of sutures they prefer-both absorbable and non-absorbable types. Technological advancements, such as tensile strength and antimicrobial coatings, are driving individuals to adopt sutures. Moreover, government healthcare initiatives as well as the improvement in surgical techniques increase demand for a high-quality suture in hospitals.

Ambulatory surgical centers (ASCs) and clinics are increasingly favored in Japan for their economical and efficient surgical options. These establishments are undertaking a rising volume of minimally invasive procedures, which in turn heightens the demand for precision sutures that facilitate expedited healing. ASCs generally utilize absorbable sutures for outpatient surgeries, thereby minimizing the necessity for subsequent removal. The growing inclination towards day-care surgeries, along with advancements in suture technology, is propelling demand in this sector. Furthermore, the transition towards outpatient care has bolstered the use of sutures engineered for faster recovery and diminished post-surgical complications.

Competitive Landscape:

The industry is highly characterized by intense research and development activities, strategic partnerships, and innovations in products. Leading Japanese manufacturers are focusing on developing advanced sutures with advanced tensile strength, biocompatibility, and antimicrobial properties, which should respond to the current demand for even more efficient and safe wound closure. Companies currently invest in the development of biodegradable and drug-eluting sutures to further reduce post-operative complications and guarantee better healing outcomes. Key participants are also looking to expand the distribution channels along with partnerships with hospitals and other surgical facilities, thereby enhancing the market presence. Innovations in technology, including smart sutures and materials compatible with robotic systems, are influencing competitive dynamics.

The report provides a comprehensive analysis of the competitive landscape in the Japan surgical sutures market with detailed profiles of all major companies.

Latest News and Developments:

  • January 07, 2025: Kaken Pharmaceutical of Japan entered into a licensing agreement valued at USD 1.2 Billion with Johnson & Johnson for the worldwide development, production, and marketing of its STAT6 inhibitor program, which encompasses KP-723. Kaken is responsible for concluding Phase I trials before Johnson & Johnson assumes control of global clinical development, while Kaken will maintain commercialization rights within Japan. The agreement features an initial payment of USD 30 Million, milestone-related payments that could reach up to USD 1.2175 Billion, along with royalties on international sales.
  • October 16, 2023: Japan's Gunze Limited announced allocating 3.5 billion JPY for the construction of a third medical facility and the expansion of its research and development laboratory in Ayabe, Kyoto, with a target completion date of February 2025. This initiative aims to strengthen its medical sector. The new plant will facilitate increased production of TENALEAF(TM), an absorbable surgical adhesive barrier, while also enhancing research and development efforts for next-generation products.

Key Questions Answered in This Report

  • 1.How big is the surgical sutures market in Japan?
  • 2.What factors are driving the growth of the Japan surgical sutures market?
  • 3.What is the forecast for the surgical sutures market in Japan?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Surgical Sutures Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Surgical Sutures Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Surgical Sutures Market - Breakup by Type

  • 6.1 Absorbable
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Nonabsorbable
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)

7 Japan Surgical Sutures Market - Breakup by Filament

  • 7.1 Monovalent
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Multivalent
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)

8 Japan Surgical Sutures Market - Breakup by Application

  • 8.1 Ophthalmic Surgery
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Cardiovascular Surgery
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)
  • 8.3 Orthopedic Surgery
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2019-2024)
    • 8.3.3 Market Forecast (2025-2033)
  • 8.4 Neurological Surgery
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2019-2024)
    • 8.4.3 Market Forecast (2025-2033)
  • 8.5 Others
    • 8.5.1 Historical and Current Market Trends (2019-2024)
    • 8.5.2 Market Forecast (2025-2033)

9 Japan Surgical Sutures Market - Breakup by End Use

  • 9.1 Hospitals
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2019-2024)
    • 9.1.3 Market Forecast (2025-2033)
  • 9.2 Ambulatory Surgical Centers and Clinics
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2019-2024)
    • 9.2.3 Market Forecast (2025-2033)

10 Japan Surgical Sutures Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Product Portfolio
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Product Portfolio
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events
  • 11.6 Company F
    • 11.6.1 Business Overview
    • 11.6.2 Product Portfolio
    • 11.6.3 Business Strategies
    • 11.6.4 SWOT Analysis
    • 11.6.5 Major News and Events
  • 11.7 Company G
    • 11.7.1 Business Overview
    • 11.7.2 Product Portfolio
    • 11.7.3 Business Strategies
    • 11.7.4 SWOT Analysis
    • 11.7.5 Major News and Events
  • 11.8 Company H
    • 11.8.1 Business Overview
    • 11.8.2 Product Portfolio
    • 11.8.3 Business Strategies
    • 11.8.4 SWOT Analysis
    • 11.8.5 Major News and Events
  • 11.9 Company I
    • 11.9.1 Business Overview
    • 11.9.2 Product Portfolio
    • 11.9.3 Business Strategies
    • 11.9.4 SWOT Analysis
    • 11.9.5 Major News and Events
  • 11.10 Company J
    • 11.10.1 Business Overview
    • 11.10.2 Product Portfolio
    • 11.10.3 Business Strategies
    • 11.10.4 SWOT Analysis
    • 11.10.5 Major News and Events

12 Japan Surgical Sutures Market - Industry Analysis

  • 12.1 Drivers, Restraints and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix